AI-generated summary
The authors report a single-blinded, placebo-controlled study of 178 adolescent and adult patients with amblyopia, treated with 780 nm low-level laser therapy to the macula. Visual acuity improved in about 90% of treated eyes, and the authors state the effect lasted at least 6 months, while the control group showed no change.
- Participants
- 178
- Who or what was studied
- Adolescent and adult patients with amblyopia caused by ametropia or strabismus (mean age 46.8 years)
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The abstract does not describe randomization or long-term follow-up beyond 6 months, and the control group was small at 20 eyes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Power
- 7.5 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Control group, Light-emitting diode, Placebo-controlled, Duty cycle, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.